AYURVEDIC PANCHAKARMA WITH CALORIE-RESTRICTED DIET SIGNIFICANTLY REDUCES HBA1C AND BMI IN TYPE 2 DIABETES MELLITUS: A RETROSPECTIVE OBSERVATIONAL STUDY FROM TWO CENTRES IN BENGALURU

  • MD and CEO, Vaidya Sane Ayurved Laboratories Limited.
  • Chief Medical Officer, Vaidya Sane Ayurved Laboratories Limited.
  • Head Medical Operations, Vaidya Sane Ayurved Laboratories Limited.
  • Zonal Medical Head, Madhavbaug Clinics, Maharashtra, India.
  • Clinic Head, Madhavbaug Sahakar Nagar Clinic, Bengaluru, Karnataka, India.
  • Clinic Head, Madhavbaug Yelahanka Clinic, Bengaluru, Karnataka, India.
  • Abstract
  • Keywords
  • How to Cite This Article
  • Corresponding Author

Background: Type 2 Diabetes Mellitus (T2DM) is a rapidly growing metabolic epidemic in India. Conventional pharmacotherapy, while effective, does not address underlying metabolic dysfunction. Ayurvedic Panchakarma-based protocols offer a holistic approach targeting glycaemic control, weight management, and metabolic restoration. Objective:To evaluate the clinical efficacy of the CDC(Comprehensive Diabetes Care) Panchakarma protocol combined with an 800 kcal calorie-restricted Prameha diet on glycaemic, anthropometric, and metabolic parameters in patients with T2DM.


Rohit Sane, et, al (2026); AYURVEDIC PANCHAKARMA WITH CALORIE-RESTRICTED DIET SIGNIFICANTLY REDUCES HBA1C AND BMI IN TYPE 2 DIABETES MELLITUS: A RETROSPECTIVE OBSERVATIONAL STUDY FROM TWO CENTRES IN BENGALURU, Int. J. of Adv. Res., 14 (06), 50-57, ISSN 2320-5407. DOI URL: https://dx.doi.org/


Rohit Sane
Zonal Medical Head, Madhavbaug Clinics, Maharashtra, India.
India